Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Affiliations

• ¹ Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
• ² Division of clinical epidemiology, Department of Medicine Solna, Karolinska Institutet, and Department of Hematology, Karolinska University hospital, Stockholm, Sweden.
• ³ Department of Public Health and Clinical Medicine, Rheumatology, Umeå University, Umeå, Sweden.
• ⁴ Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
• ⁵ Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
• ⁶ Department of Clinical Sciences, Malmö, Rheumatology, Lund University, Malmö, Sweden.
• ⁷ Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
• ⁸ Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden marie.wahren@ki.se.